Both copyright's cousin and Wegovy have emerged as innovative options for addressing obesity, but they function differently. Semaglutide injections is only approved for weight loss , while This dual-action drug initially targeted diabetes management and subsequently demonstrated impressive slimming effects, leading to a recent green light for weigh